UID:
almahu_9949913027902882
Format:
XI, 196 p. 100 illus., 30 illus. in color.
,
online resource.
Edition:
1st ed. 2024.
ISBN:
9783031758065
Series Statement:
Handbook of Experimental Pharmacology, 286
Content:
Collaborative approaches are becoming a key driver in drug discovery and development. They come in many types and forms ranging from project-based collaborations and strategic alliances to large international consortia. The volume discusses various types of such collaboration including the specific uses, advantages, and challenges. Based on the nature of public-private partnerships, we present views and experiences from academia, industry, and public stakeholders.
Note:
Novel and proven models of Public Private and Public Private Partnerships in Healthcare An Update -- Project based Public private collaborations -- Collaborative Innovations in Childhood Cancer Therapies -- Reaching outer space and enabling the mRNA revolution a critical role of partnerships for successful drug and vaccine development -- The Alliance between the German Cancer Research Center and Bayer a retrospective of an innovative collaboration model -- Life Science Incubation at LabCentral BioLabs with Partners Extending from the US to Europe -- Innovation at the Interface between Academia and Industry The BioMed X Model -- From innovator result driven to multi actor impact oriented Public Private Partnerships Integrating the patient perspective -- The Legal Framework for PPP in Drug R&D.
In:
Springer Nature eBook
Additional Edition:
Printed edition: ISBN 9783031758058
Additional Edition:
Printed edition: ISBN 9783031758072
Additional Edition:
Printed edition: ISBN 9783031758089
Language:
English
DOI:
10.1007/978-3-031-75806-5
URL:
https://doi.org/10.1007/978-3-031-75806-5
URL:
Volltext
(URL des Erstveröffentlichers)
Bookmarklink
